Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunology and world health: key contributions from the global community.

Annals of the New York Academy of Sciences·2013
Same author

Vaccines of the future.

Vaccine·2011
Same author

Public health. The cholera crisis in Africa.

Science (New York, N.Y.)·2009
Same author

Pillars article: antibody production by single cells. 1958. Nature 181: 1419-1420.

Journal of immunology (Baltimore, Md. : 1950)·2009
Same author

Evidence for the clonal abortion theory of B-lymphocyte tolerance. 1975.

Journal of immunology (Baltimore, Md. : 1950)·2007
Same author

One cell-one antibody: prelude and aftermath.

Nature immunology·2007

Related Experiment Video

Updated: May 29, 2026

Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

Vaccines and future global health needs.

G J V Nossal1

  • 1Department of Pathology, The University of Melbourne, Australia. dewhurst@wehi.edu.au

Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|September 7, 2011
PubMed
Summary
This summary is machine-generated.

Global vaccine development and deployment are expanding, with significant progress in infant vaccines and ongoing research for diseases like malaria and HIV. Funding and polio eradication remain key challenges for future vaccine initiatives.

More Related Videos

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Related Experiment Videos

Last Updated: May 29, 2026

Remote Laboratory Management: Respiratory Virus Diagnostics
14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Area of Science:

  • Vaccinology
  • Global Health
  • Preventive Medicine

Background:

  • International support for vaccine research and deployment has grown significantly.
  • The GAVI Alliance has increased uptake of essential infant vaccines and hepatitis B, yellow fever vaccines.
  • Future vaccine introductions include pneumococcal, rotavirus, human papillomavirus, meningococcal, rubella, and typhoid vaccines.

Purpose of the Study:

  • To review the progress and future directions of vaccine development and deployment globally.
  • To highlight challenges in funding and global polio eradication.
  • To discuss emerging vaccine applications beyond infectious diseases.

Main Methods:

  • Review of international initiatives and alliances (e.g., GAVI Alliance).
  • Analysis of current vaccine research and development pipelines.
  • Discussion of logistical and financial challenges in global vaccine strategies.

Main Results:

  • Significant increase in the uptake of common infant vaccines and specific disease vaccines.
  • Advanced research in vaccines for malaria, HIV/AIDS, tuberculosis, autoimmunity, and cancer.
  • Identification of funding and polio eradication as critical future challenges.

Conclusions:

  • The landscape of vaccine development and deployment is rapidly evolving, with a projected increase in available vaccines for the developing world.
  • Addressing financial constraints and completing polio eradication are paramount for global health security.
  • Future vaccine research extends beyond infectious diseases into areas like autoimmunity and cancer, with innovations in delivery and adjuvants.